Extense Pharma SPRL
Ouverture de failliteThe score of Extense Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2021
Change 2018 → 2021: Total assets -72 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Extense Pharma's annual accounts
| 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|
| Net result | −120,752 € | ||||
| Equity | −437,008 € | ||||
| Cash | 83 € | ||||
| EBITDA | −43,005 € | ||||
| Total assets | 394,215 € |
Filed annual accounts
- Year ended 31 Dec 2021filed on 24 Oct 2022
- Year ended 31 Dec 2020filed on 24 Oct 2022
- Year ended 31 Dec 2019filed on 21 Oct 2021
- Year ended 31 Dec 2018filed on 25 Jul 2019
- Year ended 31 Dec 2017filed on 28 Aug 2018
Extense Pharma's financial analysis
- Solvency-110.9%sector median: 41.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Extense Pharma
Extense Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0821.673.538
- VAT number
- BE0821673538
- Peppol
- Not found on Peppol as of 10 Nov 2026 · Check
- Legal form
- SPRL
- Incorporated
- 17 Dec 2009
- Registered office
- 1300 Wavre
- Latest accounts
- 2021 · filed on 24 Oct 2022
- Activity
- Activities of agents involved in the wholesale of other particular products (NACE 46180)
Extense Pharma (SPRL) has been based in Wavre since 2009, active in: activities of agents involved in the wholesale of other particular products. For 2021, it reports a net loss of 120,752 € and equity of −437,008 €; its revenue is not published. Its solvency stands at -110.9%, below the median of its sector (41.0%).
Companies similar to Extense Pharma
Companies in the same business, of comparable size and area, outside its group.
- VM Distribution Activities of agents involved in the wholesale of other particular products Waterloo · balance sheet 31 €
- SOKA Wholesale of other food Waterloo · balance sheet 16,927 €
- LET EAT Grow Activities of agents involved in the wholesale of other particular products Mons · balance sheet 40,825 €
- Tjammelshof Activities of agents involved in the wholesale of other particular products Wortegem-Petegem · balance sheet €1.01m
- BO-Innova Activities of agents involved in the wholesale of other particular products Brasschaat · balance sheet 137,921 €
- Aero66 Manufacture of homogenised food preparations and dietetic food Vilvoorde · balance sheet 70,101 €
- Medoxys Activities of agents involved in the wholesale of other particular products Villers-la-Ville · balance sheet 556,493 €
- La Tomaterie Activities of agents involved in non-specialised wholesale Beersel · balance sheet 356,380 €
Frequently asked questions about Extense Pharma
What is the revenue of Extense Pharma?
Extense Pharma files its accounts in a format where revenue is optional: it is not published for 2021.
What is the VAT number of Extense Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0821673538 for Extense Pharma, if the company is VAT-registered. Its company number (CBE) is 0821.673.538.
Where is the registered office of Extense Pharma?
According to the CBE register, the registered office of Extense Pharma is in 1300 Wavre.
What is the equity of Extense Pharma?
At the close of the 2021 financial year, the equity of Extense Pharma amounts to -437,008 €, a solvency of -110.9% of total assets.
Who manages Extense Pharma?
The register lists 2 active mandates at Extense Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Extense Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →